Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease
Authors:
Open Access
Abstract
BACKGROUND Degradation of the extracellular matrix and ulceration of the mucosa are major features of inflammatory bowel disease (IBD). One of the most important enzymes in degrading the matrix and produced in excess by cytokine activated stromal cells, is stromelysin-1. The activity of stromelysin-1 is controlled by tissue inhibitor of metalloproteinase (TIMP-1), its natural inhibitor. In model systems excess stromelysin-1 produces mucosal degradation. METHODS Quantitative competitive RT-PCR was used to analyse stromelysin-1 and TIMP-1 transcripts; western blotting was used to measure the amount of stromelysin-1 and TIMP-1 protein in biopsy samples from children with IBD. RESULTS In biopsies from patients with active Crohn's disease (n=24), ulcerative colitis (n=23), and controls (n=16), TIMP-1 transcripts and protein were abundant and unchanged. Stromelysin-1 transcripts and protein were markedly elevated in mucosal biopsies obtained from inflamed sites of patients with active IBD but were not elevated in adjacent endoscopically normal mucosa (n=10). Elevated levels of stromelysin-1 transcripts in active Crohn's disease (n=5) returned to normal levels following treatment with enteral nutrition. CONCLUSIONS Stromelysin-1 is markedly overexpressed at inflamed sites in patients with IBD whereas TIMP-1 remains unaltered. Excess stromelysin-1 is likely to be responsible for loss of mucosal integrity in IBD.Keywords
This publication has 42 references indexed in Scilit:
- Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation.Gut, 1996
- Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous woundsBritish Journal of Dermatology, 1996
- The effect of treatment on lymphokine‐secreting cells in the intestinal mucosa of children with Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1995
- Increased levels of stromelysin‐1 and tissue inhibitor of metalloproteinases–1 in sera from patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- TIMP‐1 protein expression is stimulated by IL‐1β and IL‐6 in primary rat hepatocytesFEBS Letters, 1994
- Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.Journal of Clinical Pathology, 1994
- Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.Gut, 1993
- Clinical evaluation of serum tissue inhibitor of metalloproteinases‐1 levels in patients with liver diseasesJournal of Gastroenterology and Hepatology, 1993
- Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.Gut, 1989
- A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in cultureBiochemical and Biophysical Research Communications, 1985